[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:autosomal-recessive-chronic-granulomatous-disease":3},{"name":4,"total":5,"trials":6,"biomarkers":15,"states":16},"Autosomal Recessive Chronic Granulomatous Disease",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06559176","A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )",[11],"Phase 1\u002FPhase 2","ENROLLING_BY_INVITATION","2026-08-03T02:04:08.415522Z","2026-06-16T05:54:07.759857Z",[],[]]